Abstract:Background Ovarian cancer (OvCa) is a malignant disease of the female reproductive system with a high mortality rate. LncRNA has been confirmed to play a crucial role in the development and progression of various cancer types. Novel lncRNA ZFHX4-AS1 has been reported in several cancers, albeit its functional mechanisms in OvCa remain unclear. Methods With reference to the public databases and based on integrating bioinformatics analyses, we explored the expression of ZFHX4-AS1 and its roles in the prognosis of OvCa. We employed the Kaplan-Meier curves to investigate the outcome of patients with different ZFHX4-AS1 expressions. Furthermore, its biological function and the related hallmark pathways were assessed through Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, and Gene-set enrichment analysis (GSEA). We explored the correlation between lncRNA ZFHX4-AS1 and tumor-infiltrating immune cells through CIBERSORT. The immune checkpoints associated with lncRNA ZFHX4-AS1 and its related genes were investigated. The effect of lncRNA ZFHX4-AS1 on proliferation, invasion and migration of OvCa cells was verified through Cell Counting Kit (CCK)-8, colony formation, wound healing and transwell assays. Results The expression of lncRNA ZFHX4-AS1 was upregulated in OvCa relative to that in normal tissues. Increased lncRNA ZFHX4-AS1 expression was associated with poor overall survival and progression-free survival in OvCa. The GO and KEGG pathway analyses revealed the role of lncRNA ZFHX4-AS1 in cell metabolism, protein synthesis, cell proliferation, and cell cycle. GSEA indicated the hallmark gene sets that were significantly enriched in the high and low expression groups. The CIBERSORT database revealed M2 macrophages, memory B-cells, naïve B cells, and activated NK cells were affected by lncRNA ZFHX4-AS1 expression (all P < 0.05). The expression of lncRNA ZFHX4-AS1 and its related differential genes MRPS11 , NSA2 , and MRPL13 were significantly correlated with the immune checkpoints. Knockdown of lncRNA ZFHX4-AS1 could inhibit the proliferation, invasion and migration of OvCa cells. Conclusions The results suggested that lncRNA ZFHX4-AS1 is a novel prognostic biomarker associated with cell proliferation, metabolism, infiltration, and distribution of tumor-infiltrating immune cells in OvCa, indicating that lncRNA ZFHX4-AS1 can be used as a potential therapeutic target for OvCa in the future.

HOXD-AS1 Promotes Cell Proliferation, Migration and Invasion Through Mir-608/Fzd4 Axis in Ovarian Cancer.

HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3

MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer

Long Non‐coding RNA SNHG1 Stimulates Ovarian Cancer Progression by Modulating Expression of Mir‐454 and ZEB1

LncRNA HOXA‐AS2 promotes the progression of epithelial ovarian cancer via the regulation of miR‐372

LncRNA RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer via upregulation of RAD51B

HOXD-AS1: a novel oncogenic long intergenic non-coding RNA in humans.

Abnormal expression of long non-coding RNA FGD5-AS1 affects the development of ovarian cancer through regulating miR-107/RBBP6 axis

Long Non-Coding Rna Hoxa-As2 Promotes Proliferation and Invasion of Breast Cancer by Acting As A Mir-520c-3p Sponge

An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer

Hsa_circ_0001741 Suppresses Ovarian Cancer Cell Proliferations Through Adsorption of Mir-188-5p and Promotion of FOXN2 Expression.

Long Non-coding RNA FOXD2-AS1 Silencing Inhibits Malignant Behaviors of Ovarian Cancer Cells Via miR-324-3p/SOX4 Signaling Axis

Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer

Long Non-Coding RNA FAM83H-AS1 Acts As a Potential Oncogenic Driver in Human Ovarian Cancer

Mir-183 Modulated Cell Proliferation and Apoptosis in Ovarian Cancer Through the TGF-β/Smad4 Signaling Pathway

LncRNA BBOX1-AS1 Aggravates the Development of Ovarian Cancer by Sequestering miR-361-3p to Augment PODXL Expression

Long Non-Coding RNA HOXD-AS1 Promotes Tumor Progression and Predicts Poor Prognosis in Colorectal Cancer

ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer

LncRNA HAND2-AS1 Exerts Anti-Oncogenic Effects on Ovarian Cancer Via Restoration of BCL2L11 As a Sponge of Microrna-340-5p

ZFHX2-AS1 interacts with DKC1 to regulate ARHGAP5 pseudouridylation and suppress ovarian cancer progression

Inhibition of Long Non-Coding RNA XIST Upregulates Microrna-149-3p to Repress Ovarian Cancer Cell Progression